Cantwell Statement on Trump’s Decimation of the National Science Board
intelligence, quantum technology, advanced manufacturing, composites, energy, and biotech -- with an authorization of $20 billion over five years
Full-text search across every press release in the archive. Matches the title and body, with English stemming, “vote” catches “voted” and “voting.”
34 results for “biotech” · Senate · Democrats
intelligence, quantum technology, advanced manufacturing, composites, energy, and biotech -- with an authorization of $20 billion over five years
between NJ and South Korea on issues like biotech, and the importance of making sure America’s immigration
said Representative Bice. “The convergence of AI and biotech is transforming what we can do with biology … million acres of national parks and enable future biotech breakthroughs in medicine, agriculture, and industrial production,” said Representative
invest in up-and-coming industries like biotech. Commerce, Justice, Science, and Related Agencies Economic Development Administration, Regional
intelligence, quantum technology, advanced manufacturing, composites, energy, and biotech -- with an authorization of $20 billion over five years
that America continues to lead in agricultural and biotech innovation. Other countries are investing heavily in this space
directly to the strength of our workforce – from biotech professionals to construction workers to nurses. Without prepared workers
leading the nation in developing an AI biotech platform that will accelerate breakthroughs in cleaner fuels, sustainable materials
United States continues to lead the world in biotech manufacturing, protecting Americans’ security and our health.” “Not only … would cut costs, speed production, and grow our biotech workforce here in our Commonwealth. As competitors like
Pensions (HELP) Committee hearing titled “The Future of Biotech: Maintaining U.S. Competitiveness and Delivering Lifesaving Cures to Patients … patients. And we’ve heard from the biotech industry, they do not have the resources to make
Intelligence Community, restrict contracts with Chinese military biotech firms, and strengthen our artificial intelligence capabilities. It also increases
problems in medicine, chemistry, material science, physics, biology, biotech… the hardest things that we have probably
into new and emerging technologies like cyber and biotech, we are making sure that we are ready
Illinois Fermentation and Agriculture Biomanufacturing (iFAB) Tech Hub, biotech company representatives and local leaders today to highlight … state ideally positioned to support the sorts of biotech opportunities that bolster our national security,”Duckworth said
security. We must prioritize American agricultural and emerging biotech innovation to strengthen our food supply chain … States at the forefront of safe, market-ready biotech development. Our bipartisan package will facilitate close interagency coordination
leadership and U.S. investments in semiconductor, energy, and biotech projects. As a member of the U.S. Senate Foreign
firms, Mithril Capital Management, where he invested in biotech companies developing medical robots, diabetes treatments, antibody technologies
ahead, and stay ahead, in developing the biotech of the future. Why? Because our very national security … industry is another day American leadership in biotech falls behind. So we have an enormous problem set before
federal agencies aligned and working on domestic biotech priorities is critical, but our Commission has found that communication … between federal agencies to build a long-term biotech strategy and secure American leadership in its development
Biotech Commission report emphasizes: Emerging biotechnology is key to continued U.S. dominance and securing future economic growth
emerging technologies such as artificial intelligence, cybersecurity, biotech, and quantum computing. With strong bipartisan support across both chambers
equipment is used in chemical, petrochemical, pharmaceutical, and biotech research labs. The company employs about 100 skilled professionals
Malaria once again reach our shores and U.S. biotech companies who will no longer sell their drugs
Malaria once again reach our shores and U.S. biotech companies who will no longer sell their drugs